News Daily News Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s Michael O'Riordan November 29, 2023
News Daily News ‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults Michael O'Riordan November 21, 2023
News Conference News PCR London Valves 2023 For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE Shelley Wood November 20, 2023
News Daily News Symplicity Spyral Approved: FDA Clears Second Renal Denervation System Todd Neale November 20, 2023
News Conference News AHA 2023 For LGBTQ+ Patients With Heart Failure, EMR Details Often Absent Caitlin E. Cox November 17, 2023
Presentation AHA 2023 Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial Presenter: Jamie Kitt November 17, 2023
Presentation AHA 2023 Hypertension Treatment in Nigeria: Early Results of a Type 2 Hybrid Effectiveness and Implementation Interrupted Time Series Trial Presenter: Dike Ojji November 17, 2023
News Daily News Mortality Risk Varies Among Patients With Very High LDL Levels Michael O'Riordan November 17, 2023
Presentation AHA 2023 Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events Presenter: Jing Li November 16, 2023
News Conference News AHA 2023 ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients Todd Neale November 13, 2023
News Conference News AHA 2023 POP-HT: Physician-Guided Self-Monitoring Improves BP After Hypertensive Pregnancy L.A. McKeown November 13, 2023
News Conference News AHA 2023 Intensive BP Reduction Lowers Dementia Risk in China Rural Hypertension Study Todd Neale November 12, 2023
News Conference News AHA 2023 Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP Michael O'Riordan November 12, 2023
News Conference News AHA 2023 Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics Todd Neale November 11, 2023
News Conference News AHA 2023 RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1 Caitlin E. Cox November 11, 2023
News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Daily News FDA Grants Tirzepatide a New Indication for Obesity Management L.A. McKeown November 08, 2023
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023
News Opinion Editor's Corner AHA 2023 What’s Going to Be Hot at AHA 2023 Shelley Wood November 07, 2023